Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2021 Jan 19;109(5):1647–1656. doi: 10.1016/j.ijrobp.2020.12.014

Table 1.

Demographic data and clinical characteristics of ES-NSCLC patients.

Characters 100-patient cohort 60-patient cohort p value
Age (Years) 70.6±11.8 71.7±9.1 0.529
Sex (M/F) 48%/52% 38%/62% 0.236
Current or former smoker 96% 97% 0.831
BMI ± Standard Deviation 27.5±6.4 26.5±5.8 0.325
Deceased 39% 22% <0.001
Local Failure 7% 18% 0.304
Nodal Failure 17% 18% 0.323
Distant Failure 9% 17% 0.946
Mean tumor size ± Standard Deviation (cm3) 1.99±0.87 1.77±0.80 0.105
Mean, median follow-up time (Month) 19.0, 16.4 28.6, 25.0 <0.001
Range of follow-up time (Month) [2.1, 47.8] [7, 54.4]
Median of prescription dose (Gy) 50 50
BED10 (Gy) 100/112.5 (5/4 fractions) 100/112.5 (5/4 fractions)